Skip to main content

Advertisement

SpringerLink
Log in

Global elimination of hepatitis C virus by 2030: why not?

  • Comment
  • Published:

From Nature Medicine

View current issue Submit your manuscript

The World Health Organization’s targets for eliminating hepatitis C virus by 2030 have been deemed ambitious by many. However, we believe they are achievable, provided they are supported by global commitment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Choo, Q. L. et al. Science 244, 359–362 (1989).

    Article  CAS  Google Scholar 

  2. Hajarizadeh, B., Grebely, J. & Dore, G. J. Nat. Rev. Gastroenterol. Hepatol. 10, 553–562 (2013).

    Article  CAS  Google Scholar 

  3. Dore, G. J. & Feld, J. J. Clin. Infect. Dis. 60, 1829–1836 (2015).

    Article  CAS  Google Scholar 

  4. World Health Organization. Global Health Sector Strategy on Viral Hepatitis, 2016–2021 (World Health Organization, Geneva, Switzerland, 2016).

    Google Scholar 

  5. Global Burden of Disease Collaborators. Lancet 390, 1151–1210 (2017).

    Article  Google Scholar 

  6. Scott, N. et al. J. Hepatol. 68, 932–939 (2018).

    Article  Google Scholar 

  7. Hajarizadeh, B., Grebely, J., Matthews, G. V., Martinello, M. & Dore, G. J. J. Viral Hepat. 25, 640–648 (2018).

    Article  CAS  Google Scholar 

  8. Moon, S. & Erickson, E. N. Engl. J. Med. 380, 607–610 (2019).

    Article  Google Scholar 

  9. Alavi, M. et al. J. Hepatol. 71, 281–288 (2019).

    Article  Google Scholar 

  10. Elsharkawy, A. et al. J. Hepatol. 68, 691–698 (2018).

    Article  CAS  Google Scholar 

  11. Larney, S. et al. Lancet Glob. Health 5, e1208–e1220 (2017).

    Article  Google Scholar 

  12. Fraser, H. et al. Addiction 113, 173–182 (2018).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Kirby Institute, University of New South Wales, Sydney, Australia

    Gregory J. Dore, Marianne Martinello, Maryam Alavi & Jason Grebely

Authors
  1. Gregory J. Dore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marianne Martinello
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maryam Alavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jason Grebely
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregory J. Dore.

Ethics declarations

Competing interests

The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. G.J.D. is an advisory board member and has received honoraria from Merck, Gilead, and Abbvie, and has received research grant funding from Merck, Gilead, and Abbvie, as well as travel sponsorship from Merck, Gilead, and AbbVie. J.G. has received research support and is a consultant for AbbVie, Cepheid, Gilead Sciences, and Merck.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dore, G.J., Martinello, M., Alavi, M. et al. Global elimination of hepatitis C virus by 2030: why not?. Nat Med 26, 157–160 (2020). https://doi.org/10.1038/s41591-019-0706-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-019-0706-x

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation